Trexquant Investment’s Biocept, Inc. BIOC Stock Holding History

Trexquant Investment’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-340	Closed	-$52K	–	1619
2021 Q1	$52K	Buy	+340	New	+$61.7K	﹤0.01%	1074

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Trexquant Investment's BIOC Position: Q2 2021 in Review

Trexquant Investment sold out of Biocept, Inc. (BIOC) in Q2 2021, closing a stake of 340 shares — an estimated $52K sold.

Trexquant Investment first reported a position in BIOC in Q1 2021 and held it in 1 quarter. The position peaked at $52K in Q1 2021. 21 funds tracked by Wall St. Rank hold BIOC as of Q2 2021.

Trexquant Investment reported no remaining Biocept, Inc. position as of Q2 2021 after selling out during the quarter.
Trexquant Investment sold 340 Biocept, Inc. shares in Q2 2021, an estimated $52K.
Trexquant Investment first reported a position in Biocept, Inc. in Q1 2021 and held it in 1 quarter.
Trexquant Investment's Biocept, Inc. position peaked at $52K in Q1 2021.
21 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2021.

Based on Trexquant Investment's 13F filing for Q2 2021, filed 12 Aug 2021.